IL153971A0 - Method for locating compounds which are suitable for the treatment and/or prophylaxis of obesity - Google Patents

Method for locating compounds which are suitable for the treatment and/or prophylaxis of obesity

Info

Publication number
IL153971A0
IL153971A0 IL15397101A IL15397101A IL153971A0 IL 153971 A0 IL153971 A0 IL 153971A0 IL 15397101 A IL15397101 A IL 15397101A IL 15397101 A IL15397101 A IL 15397101A IL 153971 A0 IL153971 A0 IL 153971A0
Authority
IL
Israel
Prior art keywords
prophylaxis
obesity
treatment
locating
compounds
Prior art date
Application number
IL15397101A
Other languages
English (en)
Original Assignee
Solvay Pharm Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Solvay Pharm Gmbh filed Critical Solvay Pharm Gmbh
Publication of IL153971A0 publication Critical patent/IL153971A0/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/26Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving oxidoreductase
    • C12Q1/32Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving oxidoreductase involving dehydrogenase
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/527Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving lyase
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/04Anorexiants; Antiobesity agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/06Antihyperlipidemics

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Wood Science & Technology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Zoology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Obesity (AREA)
  • Biotechnology (AREA)
  • Analytical Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Immunology (AREA)
  • Microbiology (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Child & Adolescent Psychology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
IL15397101A 2000-07-20 2001-07-12 Method for locating compounds which are suitable for the treatment and/or prophylaxis of obesity IL153971A0 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE10035227A DE10035227A1 (de) 2000-07-20 2000-07-20 Verfahren zum Auffinden von Verbindungen, welche zur Behandlung und/oder Prophylaxe von Fettleibigkeit geeignet sind
PCT/EP2001/008051 WO2002007821A1 (de) 2000-07-20 2001-07-12 Verfahren zum auffinden von verbindungen, welche zur behandlung und/oder prophylaxe von obesitas geeignet sind

Publications (1)

Publication Number Publication Date
IL153971A0 true IL153971A0 (en) 2003-07-31

Family

ID=7649538

Family Applications (2)

Application Number Title Priority Date Filing Date
IL15397101A IL153971A0 (en) 2000-07-20 2001-07-12 Method for locating compounds which are suitable for the treatment and/or prophylaxis of obesity
IL153971A IL153971A (en) 2000-07-20 2003-01-15 A method for finding compounds that are suitable for the treatment and / or prevention of obesity

Family Applications After (1)

Application Number Title Priority Date Filing Date
IL153971A IL153971A (en) 2000-07-20 2003-01-15 A method for finding compounds that are suitable for the treatment and / or prevention of obesity

Country Status (27)

Country Link
EP (1) EP1307262B1 (ru)
JP (1) JP2004504053A (ru)
KR (1) KR100818827B1 (ru)
CN (1) CN1443085B (ru)
AR (1) AR028730A1 (ru)
AT (1) ATE278441T1 (ru)
AU (2) AU2001277534B9 (ru)
BR (1) BR0112547A (ru)
CA (1) CA2416647A1 (ru)
CZ (1) CZ2003156A3 (ru)
DE (2) DE10035227A1 (ru)
DZ (1) DZ3393A1 (ru)
ES (1) ES2230346T3 (ru)
HK (1) HK1057499A1 (ru)
HU (1) HUP0302309A3 (ru)
IL (2) IL153971A0 (ru)
MX (1) MXPA02012907A (ru)
NO (1) NO20030233L (ru)
NZ (1) NZ523960A (ru)
PL (1) PL201165B1 (ru)
PT (1) PT1307262E (ru)
RU (1) RU2268721C2 (ru)
SK (1) SK287607B6 (ru)
TR (1) TR200402670T4 (ru)
TW (1) TWI274157B (ru)
UA (1) UA74588C2 (ru)
WO (1) WO2002007821A1 (ru)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2005110413A2 (en) 2004-05-19 2005-11-24 Solvay Pharmaceuticals Gmbh Medicaments containing n-sulfamoyl-n'-arylpiperazines for the prophylaxis or treatment of obesity and related conditions
MY147767A (en) 2004-06-16 2013-01-31 Janssen Pharmaceutica Nv Novel sulfamate and sulfamide derivatives useful for the treatment of epilepsy and related disorders
AU2006249577A1 (en) 2005-05-20 2006-11-30 Janssen Pharmaceutica N.V. Process for preparation of sulfamide derivatives
AR057570A1 (es) 2005-11-14 2007-12-05 Solvay Pharm Gmbh Derivados de n-sulfamoil-n'-benzopiranopiperidinas espirocondensadas, composiciones farmaceuticas que los comprenden, un procedimiento para su preparacion y su uso en la preparacion de medicamentos para el tratamiento de enfermedades mediadas por las isoenzimas anhidrasas carbonicas subtipos ii y/o
AR058389A1 (es) * 2005-12-19 2008-01-30 Janssen Pharmaceutica Nv Uso de derivados heterociclicos benzo-fusionados de sulfamida para el tratamiento de la obesidad
US8716231B2 (en) 2005-12-19 2014-05-06 Janssen Pharmaceutica Nv Use of benzo-fused heterocycle sulfamide derivatives for the treatment of pain
US8691867B2 (en) 2005-12-19 2014-04-08 Janssen Pharmaceutica Nv Use of benzo-fused heterocycle sulfamide derivatives for the treatment of substance abuse and addiction
US8497298B2 (en) 2005-12-19 2013-07-30 Janssen Pharmaceutica Nv Use of benzo-fused heterocycle sulfamide derivatives for lowering lipids and lowering blood glucose levels
US8937096B2 (en) 2005-12-19 2015-01-20 Janssen Pharmaceutica Nv Use of benzo-fused heterocyle sulfamide derivatives for the treatment of mania and bipolar disorder
JP2009537635A (ja) 2006-05-19 2009-10-29 ジヤンセン・フアーマシユーチカ・ナームローゼ・フエンノートシヤツプ 癲癇の処置のための共同−療法
US8455432B2 (en) 2007-01-25 2013-06-04 Verva Pharmaceuticals Ltd. Insulin sensitisers and methods of treatment
CA2729056A1 (en) 2008-06-23 2010-01-21 Janssen Pharmaceutica Nv Crystalline form of (2s)-(-)-n-(6-chloro-2,3-dihydro-benzo[1,4]dioxin-2-ylmethyl)-sulfamide
US8815939B2 (en) 2008-07-22 2014-08-26 Janssen Pharmaceutica Nv Substituted sulfamide derivatives
KR20150023405A (ko) * 2012-05-24 2015-03-05 베바 파마슈티칼스 엘티디 간 기능 개선 방법
CN106770611B (zh) * 2016-12-22 2019-01-29 广西师范大学 一种用于细胞原位检测小分子化合物进入线粒体的方法
RU2771430C1 (ru) * 2021-09-21 2022-05-04 Федеральное государственное бюджетное научное учреждение "Научный центр неврологии" (ФГБНУ НЦН) Способ количественного определения антиконвульсантов в плазме крови больных эпилепсией

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4552897A (en) * 1983-02-01 1985-11-12 American Cyanamid Company Salts of 1-(aminodihalophenyl)-2-aminoethanols and antilipogenic compositions prepared therefrom
US6288095B1 (en) * 1987-09-04 2001-09-11 Beecham Group P.L.C. Compounds
US5126324A (en) * 1990-06-07 1992-06-30 Genentech, Inc. Method of enhancing growth in patients using combination therapy
DE69305091T2 (de) * 1992-10-29 1997-03-13 Genentech Inc Methode zur behandlung oder verhütung von fettleibigkeit
AU693478B2 (en) * 1994-11-10 1998-07-02 Metabolic Pharmaceuticals Limited Treatment of obesity
AP1285A (en) * 1996-06-28 2004-06-24 Ortho Mcneil Pharm Inc Anticonvulsant sulfamate derivatives useful in treating obesity.
US20030100594A1 (en) * 2001-08-10 2003-05-29 Pharmacia Corporation Carbonic anhydrase inhibitor

Also Published As

Publication number Publication date
UA74588C2 (en) 2006-01-16
TR200402670T4 (tr) 2004-11-22
AU2001277534B9 (en) 2006-02-23
HUP0302309A2 (hu) 2003-11-28
CN1443085A (zh) 2003-09-17
NZ523960A (en) 2004-12-24
PL201165B1 (pl) 2009-03-31
BR0112547A (pt) 2003-07-01
NO20030233D0 (no) 2003-01-17
KR20030022284A (ko) 2003-03-15
KR100818827B1 (ko) 2008-04-01
EP1307262A1 (de) 2003-05-07
HUP0302309A3 (en) 2005-06-28
DZ3393A1 (fr) 2002-01-31
ES2230346T3 (es) 2005-05-01
AU2001277534B2 (en) 2005-09-29
JP2004504053A (ja) 2004-02-12
DE50104023D1 (de) 2004-11-11
SK287607B6 (sk) 2011-03-04
MXPA02012907A (es) 2003-09-22
HK1057499A1 (en) 2004-04-08
SK612003A3 (en) 2003-06-03
NO20030233L (no) 2003-03-19
EP1307262B1 (de) 2004-10-06
ATE278441T1 (de) 2004-10-15
CA2416647A1 (en) 2003-01-20
CZ2003156A3 (cs) 2003-06-18
WO2002007821A1 (de) 2002-01-31
IL153971A (en) 2009-07-20
TWI274157B (en) 2007-02-21
PL363518A1 (en) 2004-11-29
AR028730A1 (es) 2003-05-21
RU2268721C2 (ru) 2006-01-27
AU7753401A (en) 2002-02-05
DE10035227A1 (de) 2002-01-31
PT1307262E (pt) 2004-12-31
CN1443085B (zh) 2010-04-28

Similar Documents

Publication Publication Date Title
PL364995A1 (en) Method for the treatment or prevention of flavivirus
AU8870701A (en) Materials and methods for the treatment or prevention of obesity
PL369237A1 (en) Micro-organisms for the treatment of soil and process for obtaining them
GB0014969D0 (en) Novel method of treatment
EP1416961A4 (en) COMPOSITION AND METHOD FOR THE TREATMENT OF A DISEASE
HK1057499A1 (en) Method for locating compounds which are suitable for the treatment and/or prophylaxis of obesity
EP1337255A4 (en) USE OF P38 INHIBITORS FOR THE TREATMENT OF INFLAMMATORY COUGH
AU2001277534A1 (en) Method for locating compounds which are suitable for the treatment and/or prophylaxis of obesity
EP1442062A4 (en) METHOD FOR TREATING CARCINOMA
HUP0302739A3 (en) Method for the treatment of tobacco
AU2002364171A8 (en) Materials and methods for the treatment or prevention of obesity
EP1359885A4 (en) NOS-HEMMER FOR THE TREATMENT OF WRINKLES
AU7750100A (en) Method for the treatment of obesity
EP1389105A4 (en) METHOD OF TREATMENT
AU6137801A (en) Method and composition for the treatment of angiogenesis
PL366404A1 (en) Method of treatment
GB0008921D0 (en) Method of treatment
GB0118892D0 (en) Method of treatment
SI1307262T1 (en) Method for locating compounds which are suitable for the treatment and/or prophylaxis of obesity
GB0027001D0 (en) Method and apparatus for the treatment of sludge
IL161630A0 (en) Methods of treating endometreosis
GB0001861D0 (en) Method for the treatment of obesity
AU2000272704A1 (en) Use of compounds for the treatment of obesity
GB0023387D0 (en) Method and apparatus for treatment of conduits and the like
GB9924275D0 (en) Method for the treatment of obesity